Skip to main content
logo
Delta-Fly Pharma, Inc. (TYO:4598)
Japan flag Japan · Delayed Price · Currency is JPY
99.00
-1.00 (-1.00%)
Oct 9, 2026, 3:30 PM JST

Delta-Fly Pharma Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
1,4632,5305,5956,9296,5606,937
Market Cap Growth
-71.89%-54.78%-19.26%5.62%-5.43%-5.49%
Enterprise Value
1,3802,2904,8575,2025,7635,596
Last Close Price
99.00195.00575.00842.001030.001280.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
-----23.12
PB Ratio
-7.4676.6720.275.638.305.63
P/TBV Ratio
-76.6720.275.638.305.63

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-----18.65

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
0.42-4.39-1.23-1.15-1.07-1.03
Net Debt / EBITDA Ratio
0.050.090.201.010.641.32
Net Debt / FCF Ratio
-0.090.181.110.651.35
Asset Turnover
-----0.17
Quick Ratio
0.300.952.495.887.3413.93
Current Ratio
0.320.982.535.947.5314.07
Return on Equity (ROE)
-736.84%-1051.78%-228.40%-141.41%-131.35%-58.43%
Return on Assets (ROA)
-221.68%-295.04%-111.90%-73.69%-73.71%-34.47%
Return on Capital Employed (ROCE)
850.50%-4720.60%-614.40%-113.80%-166.20%-77.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-114.82%-64.23%-30.76%-20.62%-20.24%-13.94%
FCF Yield
-106.42%-61.54%-32.78%-18.47%-19.86%-13.55%
Buyback Yield / Dilution
-33.77%-31.55%-22.38%-26.91%-4.61%-17.64%